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Abstract This experiment chooses nonobese diabetic (NOD)
mouse as the animal model of Sjögren’ss y n d r o m ea n d
investigates the morphologic changes, the expression of
inflammatory factors and growth factors of this mouse’s
lacrimal gland in response to a combined treatment of
traditional Lei-huo-jiu therapy alone and in combination with
Chinese medicine. The methods were to (1) use a morpholog-
ical approach to directly observe pathological changes of the
lacrimal gland in response to combined treatment and (2) to
detect the level of tumor necrosis factor (TNF)-α,i n t e r l e u k i n
(IL)-1, and nuclear factor kappa B (NF-κB) in lacrimal gland
tissue caused by the combined treatments using a immuno-
histochemical approach. There is a reduction of the mast cell’s
degranulation and modulation of the level of cytokines in
TNF-α,I L - 1 ,a n dN F - κB in the combined therapy group. The
combined treatment of traditional Lei-huo-jiu therapy with
Chinese medicine canimprovethepathologicalchangesofthe
lacrimal gland tissue of the NOD mouse through modulating
the level of TNF-α,I L - 1 ,a n dN F - κB which results in
improved tear secretion and function of the lacrimal gland.
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Introduction
Sjögren’s syndrome (SS) is a tear deficiency which includes
both primary and secondary dry eye. Primary dry eye has
the main symptom of dryness of the mouth and eye, while
secondary dry eye is caused by autoimmune phenomena.
Epidemiology indicates that the rate of dry eye is 0.5% and
3–5% following the San Diego Standard [1] and the Europe
Standard [2], respectively. The main pathological course of
SS is leukocytic infiltration of the lacrimal and salivary
glands, which release a series of cytokines leading to the
inflammation and destruction of glandular tissues, with
resultant tear and salivary deficiency. The etiological agent
for SS is not known. Many studies have investigated the
protein content of tears of Sjögren’s syndrome patients,
which includes the autoimmune cytokines, inflammational
cytokines, growth factors, and so on.
While the treatment for SS has been limited to topical
lubricants and cyclosporine, traditional Chinese medicine
(TCM) may hold promise as a complementary measure to
existing therapy. Our clinical observations have indicated
that using Lei-huo-jiu in a moxibustion technique to
infiltrate the area around both eyes of SS has yielded
positive effects. To test our clinical observation, this
experiment investigates the mechanisms of the combined
treatment of traditional Lei-huo-jiu therapy alone and in
combination with Chinese herbal medicines using a murine
model for SS. To test the response to treatment, we will
examine the lacrimal gland’s secretory capacity by morpho-
logical methods and will measure inflammatory cytokines
and growth factors in lacrimal gland tissue using an
immunohistochemical approach.
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Experiment materials
Animal model selection There were thirty female nonobese
diabetic (NOD) mice with SPF grade, aged 5 weeks old,
and body weight 17.0~20.2 g and ten female KunMing
mouse with SPF grade and aged 5 weeks old. Mice were
provided by Chinese Academy of Medical Sciences.
Experimental Chinese medicines (1) Zhao shi Lei-huo-jiu,
ChongQing Zhao Shi Lei-huo-jiu was provided by the
Traditional Medicine Institute and (2) Chinese medicine
(Yang Yin Sheng Jin fang) was from Hong shen, Mai dong,
Tian hua fen, Wu wei zi, Bo he, and so on.
Main reagents These are 4% paraformaldehyde, Bouin solu-
tion, bitter acid, gradient alcohol (70–100%), xylene, hematox-
ylin–eosinstain,acetone,tumornecrosisfactor(TNF)antibody,
interleukin (IL)-1antibody, nuclear factor kappa B (NF-κB)
antibody, ChemMateTMEnVision+/HRP immunohistochemis-
try kit (DAKO Co.), and DAB developer (DAKO Co.).
Custom-designed smoking box for mice undergoing
Lei-huo-jiu therapy This box was 70×40×50 cm
3, trans-
parent top with six round air holes (each 1 cm
2) convenient
to observe the animal’s condition in box during treatment,
and one treatment hole (diameter 4 cm) on each side for the
Lei-huo-jiu stick.
Groups
NOD rats, whose exocrine glands demonstrate groups
lymphocytic infiltration, have been certified as the ideal
animal model of SS.
1. Control group: ten KunMing mice
2. Model group: ten NOD mice
3. Lei-huo-jiu therapy group: ten NOD mice
4. The combined therapy of Lei-huo-jiu therapy and
Chinese medicine group: ten NOD mice
Methods
Administration methods Neither the control group nor the
model group underwent treatment. In Lei-huo-jiu therapy
group, Lei-huo-jiu treatment was 20 min and bid for
4 weeks. In the combined therapy group, Lei-huo-jiu
treatment was 20 min and bid, plus Chinese herbal
medicinal broth with intragastric administration and bid.
The dose is calculated according to body weight of the
mouse. Duration of treatment is 4 weeks.
Lei-huo-jiu therapy Place the two treatment groups of mice
into a smoking box and light two Lei-huo-jiu sticks, then
insert them into the box through the side holes. Sticks were
kept lit throughout 30 min of treatment. Mice were
observed during treatment to ensure normal activity during
smoking treatment session.
Specimen and stain Mice were executed and both lacrimal
glands were fixed in 4% formalin solution for 24 h, then
placed into gradient alcohol for dehydration, and finally
embedded into paraffin and cut into 3-μm sections and
stained with hematoxylin and eosin.
Morphological observation Morphological changes of the
mice’s lacrimal tissues were observed using an optical
microscope.
Immunohistochemical detection Once dewaxed, paraffin
sections are put into 0.3% H2O2 solution for blocking
endogenous peroxidase, specimens were then douched with
lotic water, then into phosphate-buffered saline (PBS) for
5 min, and this was repeated three times before placing into
the humid box. Dilute the TNF antibody (1:100), IL-1
antibody (1:50), and NF-κB antibody (1:100) with antibody
dilution as first antibody, dropwise apply 50μLo ff i r s t
antibody fluid onto each section, and 4°C refrigerate for
24 h, laying negative control at the same time. Dropwise
apply 50μL of second antibody fluid onto each section after
24 h, incubate for 1.5 h at room temperature, then place into
PBS buffer, soak for 5 min, and repeat three times, followed
by coloration, dehydration, transparence, and mounting.
Outcome analysis Picking the upper, middle, and lower three
optical fields, we took photographs in bright field for the
immunohistochemical specimens using a light microscope.
Fig. 1 Nomal Kun Ming mice’s lacrimal gland tissue, HE ×400
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intensity by using the Image Plus Pro image analysis
system and undertake quantitative analysis. Calculate the
integrated optical density (IOD): IOD=area×density.
Statistic analysis Use SPSS software for statistical analysis.
Result
Light microscopic observation
Lacrimal gland tissue in control group Lacrimal gland
tissue consists of glandular acini, which are round or
irregular cellular islands, with a central air space. Surround-
ing glandular acini are endothelial secretory cells which are
lined up in order, with an intermittent arrangement of
myoepithelial cells. Acini of the lacrimal gland are grouped
in lobules which are separated by fibrous tissue (Fig. 1).
Lacrimal gland tissue in model group Endothelial secretory
cells of the acini line up in a disorderly fashion, and their
secretory granules are lost, so the cells flatten and the acinar
lumina expand (Fig. 2). While some endothelial secretory
cells accumulate great number of secretory granules, the
acinar lumina disappear or collapse (Fig. 3). Some cavities
are full of deep brown globular structures. To add to the
abnormal appearance, grain-doff mast cells are observed in
the connective tissue surrounding the lacrimal gland tissue
(Fig. 4).
Fig. 2 In model group, endothecium secretory cells of gland
alveoluses flatten and the acinar lumina expand. Some cavities are
full of deep-brown globular structures, HE ×400
Fig. 3 In model group, some endothecium secretory cells of gland
alveoluses accumulate great of secretory granules, so the acinar
lumina disappear or collapse, HE ×1,000
Fig. 4 In model group, grain-doff mast cells are observed in
connective tissue surrounding the lacrimal gland tissue, toluidine blue
stain ×400
Fig. 5 The lacrimal gland tissue’s pathological changes in the
combined therapy group, HE ×400
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model group, pathological changes of the lacrimal gland
tissue are less pronounced in the combined therapy group.
There is less disorder of the endothelial secretory cells of
the acini, with less distention or collapsed of acinar lumina
(Figs. 5 and 6). Pathological changes of lacrimal gland
tissue in Lei-huo-jiu therapy group is slightly improved
when compared with the combined therapy group.
Expression of three inflammatory factors in lacrimal gland
tissue
Expression of TNF-α in lacrimal tissue
TNF-α is present in the interstitium surrounding acinous
cells in control group, showing up buff (Fig. 7). In the model
group, there is greater expression of TNF-α,w i t hb o t ha r e a
and stain intensity increased compared to that of the control
group (Fig. 8). In both treatment groups, TNF-α is observed
to less than in the model group, with a comparatively
reduced area and stain intensity (Figs. 9 and 10).
Expression of IL-1 in lacrimal tissue
IL-1 is present in the interstitium surrounding acinous cells
in the control group, showing up buff (Fig. 11). In the
model group, there is relatively increased expression, with
both area and stain intensity greater than that seen in the
control group (Fig. 12). In the combined therapy group, IL-1
is present to a lesser degree than in model group, both in area
and stain intensity (Fig. 13), while in Lei-huo-jiu alone
treatment group, there is no apparent difference compared to
the model group (Fig. 14).
Fig. 7 TNF-α is observed to depress in interstitium surrounding
acinous cells in control group, showing up buff, ×200
Fig. 6 The lacrimal gland tissue’s pathological changes in Lei-huo-jiu
therapy group, HE ×400
Fig. 8 In model group TNF-α is observed to depress more, showing
up buff, ×200
Fig. 9 TNF-α is observed to depress less in Lei-huo-jiu therapy
group, ×200
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NF-κB is present in the interstitium surrounding acinous
cells in the control group, showing up buff (Fig. 15). In the
model group, there is relatively increase expression, both
area and stain intensity greater than that seen in the control
group (Fig. 16). In both treatment groups, NF-κBi s
reduced compared to the model group, both in area and
stain intensity (Figs. 17 and 18).
Computer image analysis
Compared with the control group, the IODs of TNF-α,I L - 1 ,
and NF-κB are larger in model group (P<0.05 and P<0.01,
respectively). Compared with the model group, the IOD
of all three cytokines is lower in the combined therapy
group (P<0.05), and the IOD of TNF-α and NF-κB,
but not IL-1, is lower in the Lei-huo-jiu therapy group
(P<0.05). Table 1
Discussion
Animal model
SS is an autoimmune disease with lymphocytic infiltration
of the exocrine glands as a distinct pathologic feature of the
disease. NOD mice, whose exocrine glands show lympho-
cytic infiltration, have been generally accepted as an ideal
animal model for SS. Researches of NOD mice have shown
Fig. 10 TNF-α is observed to depress less in the combined therapy
group, ×200
Fig. 11 IL-1 is observed to depress in interstitium surrounding
acinous cells in control group, showing up buff, ×200
Fig. 12 In model group, IL-1 is observed to depress more, showing
up buff, ×200
Fig. 13 In Lei-huo-jiu therapy group, no difference was observed as
compared with the model group, ×200
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lacrimal gland, submaxillary gland, and other organs of
these animals [3]. Humphreys Beher [4] confirmed that for
NOD mice, the lacrimal gland’s function is reduced. We
have observed pathological changes in 5-week-old NOD
mice, when infiltration of inflammatory cells begins to
appear in their lacrimal glands. This inflammation in
lacrimal gland is consistent with the distinctive pathological
change of SS.
When compared with control group, the lacrimal gland
of the untreated NOD model group has several differences:
(1) There are groups of infiltrating inflammatory cells. (2)
Endothelial secretory cells of glandular acini line up in an
obviously disorderly manner and their secretory granules
are lost, so that the cells flatten and the acinar lumina
appear to be distended (Fig. 2). (3) Other endothelial
secretory cells accumulate a great number of secretory
granules, to the degree that the acinar lumina disappear or
collapse (Fig. 3). This indicates that those secretory
granules are difficult to discard, and such inspissation of
these granules may aggravate local inflammation. Some
cavities are full of deep brown globular structures. (5)
Grain-doff mast cells are observed in connective tissue
surrounding the lacrimal gland tissues (Fig. 4).
Activated mast cells produce remarkable effects which
include the infiltration of lymphocytes to participate in the
release of various mediators and cytokines [5]. Since grain-
doff mast cells cannot be found in the control group, we
speculate that some of the inflammatory cytokines may
arise from the grain-doff mast cells, but this requires
confirmation. These three morphological changes which
we have observed in the NOD mouse’s lacrimal gland are
Fig. 15 NF-κB is observed to depress in interstitium surrounding
acinous cells in control group, showing up buff, ×200
Fig. 14 IL-1 is observed to depress less in the combined therapy
group, ×200
Fig. 16 In model group, NF-κB is observed to depress more, showing
up buff, ×200
Fig. 17 NF-κB is observed to depress less in Lei-huo-jiu therapy
group, ×200
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related research [6–13], so it is here further supported as an
ideal animal model of SS.
The traditional therapy for the NOD mouse’s lacrimal gland
In TCM terms, “Zhao Shi Lei-huo-jiu” is a moxibustion
treatment that delivers Chinese herbs in a strong smoke
which is thought to adjust the QI–blood of an organism’s
meridians. This effect is very similar to acupuncture.
Related empirical study has confirmed that it can advance
local blood circulation rapidly and promote topical metab-
olism and function. According to TCM theory, we chose
Hong shen, Mai dong, Wu weizi, Tian huafen, and Bo he to
compose our formula. In the formula, Hong shen benefits
vital energy and promotes the production of body fluid;
Mai dong, Wu weizi nourishes yin; Tian huafen removes
heat to promote salivation; and Bo he is cool.
After 4 weeks of treatment, the results show that (1) in
both the Lei-huo-jiu therapy group and the combined
therapy group, pathological changes of NOD mice’s
lacrimal gland are improved compared with the model
group; (2) deep brown globular structures are observed in
all the NOD mice groups, while in Lei-huo-jiu therapy and
the combined therapy groups, this phenomenon is reduced;
and (3) grain-doff mast cells are observed in connective
tissue surrounding the lacrimal gland tissue in all the
untreated NOD mice, while in the two treated groups, there
is a reduction of the population of grain-doff mast cells. We
presume that the curative effect following traditional treat-
ments is that they may reduce local inflammation and
promote the lacrimal gland’s secretory function.
The traditional therapy for NOD mice’s inflammational
cytokines in lacrimal gland
Some researches indicated that there is an elevated level of
TNF and IL-1 in SS patients’ blood, and the level of these
two cytokines is related to pathological grading. Research-
ers consider that these two cytokines play an important role
in autoimmune diseases. In the clinical setting, it is difficult
to harvest the lacrimal gland. Thus, research to investigate
inflammatory cytokines in lacrimal tissue has been rarely
conducted.
We detected levels of TNF-α, IL-1, and NF-κBi n
lacrimal gland tissue using an immunohistochemical ap-
proach. The results show that the levels of TNF-α, IL-1,
and NF-κB are higher in model group when compared to
the control group. On the other hand, when compared with
the model group, the levels of all these three cytokines are
lower in the combined therapy group. Levels of TNF-α and
NF-κB were lower in the Lei-huo-jiu therapy alone group,
but the level of IL-1 was not decreased as it was in the
combined therapy group. To some degree, the addition of
the Chinese herbal therapy in the gastric lavage potentiated
the therapy to reduce all three inflammatory cytokines in
lacrimal gland. It appears that inflammatory mechanisms
are at play, and therapy to reduce these inflammatory
cytokines can improve the pathological changes of the
lacrimal gland of NOD mice. Further studies are needed to
understand the relatively higher levels of NF-κB in relation
Fig. 18 NF-κB is observed to depress less in the combined therapy
group, ×200
Table 1 Computer image analysis for IOD of three inflammatory cytokines (IOD=area×density)
Group TNF-α (IOD) IL-1 (IOD) NF-κB (IOD)
Control group 206,811.8±333.87 1,861,260±371.32 1,949,437±426.72
Model group 1,813,602±200.92** 2,325,086±510.41* 2,411,554±355.95*
Lei-huo-jiu therapy group 1,449,907±518.56*** 2,412,896±421.73 1,894,509±392.81***
Combined therapy group 1,478,449±232.39**** 1,949,694±316.44**** 2,165,945±386.39****
*P<0.05 (model group is significantly different as compared with control group); **P<0.01 (model group is significantly different as compared
with control group); ***P<0.05 (Lei-huo-jiu therapy group is observed to be different as compared with model group); ****P<0.05 (the
combined therapy group is significantly different as compared with model group)
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the model group and what role it may play in pathogenesis
of SS.
Conclusion
Lei-huo-jiu therapy alone and combined therapy can
modulate the level of inflammatory markers in lacrimal
gland in an animal model of Sjögren’s syndrome. We
speculate that inflammatory mechanisms may be at play in
the pathological changes of lacrimal tissues since these
changes improve with treatment. Further studies are
needed to confirm this pathophysiological mechanism of
disease.
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